BIOMAT Database Logo BIOMAT Database Logo

[Fibrinolysis and thrombolytic therapy under laboratory control]. 1966

W Osten

UI MeSH Term Description Entries
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

W Osten
THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
May 1964, Journal of clinical pathology,
W Osten
[Thrombolytic therapy. (Therapeutic fibrinolysis)].
January 1978, Medicinski arhiv,
W Osten
[Laboratory control of thrombolytic therapy with streptokinase].
April 1962, Ugeskrift for laeger,
W Osten
[Mechanism of fibrinolysis and thrombolytic therapy].
January 2000, Ukrains'kyi biokhimichnyi zhurnal (1999 ),
W Osten
[Dosage and laboratory control in thrombolytic therapy with streptokinase].
November 1972, Kardiologiia,
W Osten
Thrombosis, fibrinolysis, and thrombolytic therapy: a perspective.
January 1991, Progress in cardiovascular diseases,
W Osten
Proteolysis, fibrinolysis, and coagulation. Significance in thrombolytic therapy.
October 1962, Circulation,
W Osten
[Fibrinolysis and thrombolytic drugs].
April 1992, Der Internist,
W Osten
[Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
January 1984, Voprosy meditsinskoi khimii,
W Osten
Understanding the enzymology of fibrinolysis and improving thrombolytic therapy.
June 2005, FEBS letters,
Copied contents to your clipboard!